Author: Bronwyn Jane

Dementia is a complex and often misunderstood condition, affecting millions worldwide. Julie Holder, a dementia nurse with over two decades of experience, offers a unique perspective on the early signs, diagnosis, and management of dementia. In this article originally published on The Telegraph, she sheds light on the condition and highlight the importance of personalized…

Imagine a world where a simple blood test can detect Alzheimer’s disease long before symptoms appear. A recent study published in JAMA Neurology by researchers from Sweden’s Gothenburg University suggests this might soon be reality. Their breakthrough in the p-tau217 immunoassay blood test promises a revolution in early Alzheimer’s diagnosis. Development and testing of SOBA…

Facing an early Alzheimer’s diagnosis, Simon Nicholls’s story, originally published on CNN, shines a light on the possibilities of lifestyle changes and scientific innovation in the battle against this disease. His journey from despair to remarkable cognitive improvement underscores the potential of non-pharmaceutical approaches in managing Alzheimer’s, offering hope and insights for millions worldwide. Simon…

The Guardian reports that Alzheimer’s treatment is on the verge of a significant shift with the potential approval of two groundbreaking drugs, Lecanemab and Donanemab, in the UK. These medications, the first to slow Alzheimer’s progression, offer new hope in the ongoing fight against this disease. Groundbreaking developments Lecanemab, developed by Eisai, and Donanemab, by…

A Fox News article recently reported a significant breakthrough in research for the treatment of Alzheimer’s disease. The study was published in The New England Journal of Medicine on January 11, 2024. Researchers have combined focused ultrasound with antibody therapies to enhance drug delivery to the brain, showing promising results in accelerating the removal of…

A University of California San Francisco expert has reported that the journey to effective Alzheimer’s disease (AD) treatments has spanned over 30 years and is characterized by numerous setbacks and gradual progress. Today, new therapies like anti-amyloid antibodies offer promising advances, yet the path to these developments has been fraught with challenges. Early efforts and…